| For: | Jain L, Kaur J, Ayub S, Ansari D, Ahmed R, Dada AQ, Ahmed S. Fentanyl and xylazine crisis: Crafting coherent strategies for opioid overdose prevention. World J Psychiatry 2024; 14(6): 760-766 [PMID: 38984339 DOI: 10.5498/wjp.v14.i6.760] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3206/full/v14/i6/760.htm |
| Number | Citing Articles |
| 1 |
Henry Li, Samina Ali, Jessalyn K. Holodinsky, Grant Innes, Jake Hayward. Emergency Department Prescribing and Opioid-Related Harms Among Adolescents in Alberta: 2010-2020. Pediatrics 2026; 157(5) doi: 10.1542/peds.2025-071974
|
| 2 |
Luz A. Silva-Torres, Ashraf Mozayani. Xylazine abuse, the growing risk: A review of its effects, upsurge use and associated fatalities in the USA and Puerto Rico. Journal of Forensic and Legal Medicine 2024; 108 doi: 10.1016/j.jflm.2024.102780
|
| 3 |
Domenico Iacopetta, Alessia Catalano, Francesca Aiello, Inmaculada Andreu, Maria Stefania Sinicropi, Giovanni Lentini. Xylazine, a Drug Adulterant Whose Use Is Spreading in the Human Population from the U.S. to the U.K. and All Europe: An Updated Review. Applied Sciences 2025; 15(6) doi: 10.3390/app15063410
|
| 4 |
Kitty H. Gelberg, Fernando Montero, Mingway Chang, Mary R. Russo, Matthew R. Lootens, James L. David, Redonna Chandler, Emmanuel Oga, Louisa Gilbert, Nabila El-Bassel. Xylazine Test Strip Use Among People Who Use Drugs in New York State. Journal of Addiction Medicine 2026; 20(4) doi: 10.1097/ADM.0000000000001550
|
| 5 |
Manuela Luís Oliveira da Silva, Joana Barbosa, Ricardo Jorge Dinis-Oliveira. New trends in the overdose epidemic: postural impact on abusers of fentanyl and xylazine and clinical and forensic implications. Forensic Science, Medicine and Pathology 2026; doi: 10.1007/s12024-026-01331-5
|
| 6 |
Thomas L Miller, Jeanette Mathews, George C Dungan, Joseph V Pergolizzi, Robert B Raffa. ENA-001 Reverses Xylazine/Fentanyl Combination-Induced Respiratory Depression in Rats: A Qualitative Pilot Study. Cureus 2024; doi: 10.7759/cureus.74826
|
| 7 |
Melissa R. Lewis, D. Matthew Walentiny. Respiratory depressant interactions of fentanyl and xylazine and their reversal by naloxone and yohimbine in mice. Neuropharmacology 2026; 299 doi: 10.1016/j.neuropharm.2026.111106
|
| 8 |
Savannah P. Alexander, Elizabeth Shelton, Matthew Lee, G Tharp, Michael P. McNeil, Melanie Bernitz, Kevin Graves, Lisa R. Metsch, Rachel C. Shelton. Applying the Consolidated Framework for Implementation Research (CFIR) to understand college health administrator perceptions on adopting and implementing opioid overdose education and naloxone distribution (OEND) programs among universities nationally. Harm Reduction Journal 2026; 23(1) doi: 10.1186/s12954-025-01379-6
|
| 9 |
Donald E. Greydanus, Ahsan Nazeer, Dilip R. Patel. Opioid use and abuse in adolescents and young adults; dealing with science, laws and ethics: Charming the COBRAS. Disease-a-Month 2025; 71(3) doi: 10.1016/j.disamonth.2025.101853
|
| 10 |
Cory B. Lutgen, Elisabeth Callen, Elise Robertson, Tarin Clay, Gabriela Gaona, Kathryn Cates‐Wessel, Yalda Jabbarpour, Melissa K. Filippi. Assessment of primary care team‐based learning sessions for opioid use disorder. The American Journal on Addictions 2025; 34(6) doi: 10.1111/ajad.70050
|